Serum Derivatives of Reactive Oxygen Metabolites are Associated with Severity of Chronic Obstructive Pulmonary Disease and Affected by a p53 Gene Polymorphism

References

• Pryor WA. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Persp. 1997;105(Suppl 4):875–882. doi:10.1289/ehp.97105s4875
   PubMed Web of Science ®Google Scholar
• Gwinn MR, Vallyathan V. Respiratory burst: role in signal transduction in alveolar macrophages. J Toxicol Environ Heal Part B. 2007;9(1):27–39. doi:10.1080/15287390500196081
   Web of Science ®Google Scholar
• Almkvist J, Dahlgren C, Leffler H, Karlsson A. Activation of the neutrophil nicotinamide adenine dinucleotide phosphate oxidase by galectin-1. J Immunol. 2002;168(8):4034–4041. doi:10.4049/jimmunol.168.8.4034
   PubMed Web of Science ®Google Scholar
• Roos WP, Kaina B. DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett. 2013;332(2):237–248. doi:10.1016/j.canlet.2012.01.007
   PubMed Web of Science ®Google Scholar
• Mizuno S, Bogaard HJ, Gomez-Arroyo J, et al. MicroRNA-199a-5p Is associated with hypoxia-inducible factor-1α expression in lungs from patients with COPD. Chest. 2012;142(3):663–672. doi:10.1378/chest.11-2746
   PubMed Web of Science ®Google Scholar
• Siganaki M, Koutsopoulos AV, Neofytou E, et al. Deregulation of apoptosis mediators’ p53 and bcl2 in lung tissue of COPD patients. Respir Res. 2010;11(1):46. doi:10.1186/1465-9921-11-46
   PubMed Web of Science ®Google Scholar
• Morissette MC, Vachon-Beaudoin G, Parent J, Chakir J, Milot J. Increased p53 Level, Bax/Bcl-x L Ratio, and TRAIL receptor expression in human emphysema. Am J Resp Crit Care. 2008;178(3):240–247. doi:10.1164/rccm.200710-1486oc
   PubMed Web of Science ®Google Scholar
• Lee YL, Chen W, Tsai WK, et al. Polymorphisms of p53 and p21 genes in chronic obstructive pulmonary disease. J Lab Clin Med. 2006;147(5):228–233. doi:10.1016/j.lab.2005.12.008
   PubMed Web of Science ®Google Scholar
• Mizuno S, Bogaard HJ, Kraskauskas D, et al. p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice. Am J Physiol-Lung C. 2011;300(5):L753–L761. doi:10.1152/ajplung.00286.2010
   PubMed Web of Science ®Google Scholar
• Walker KK, Levine AJ. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc National Acad Sci. 1996;93(26):15335–15340. doi:10.1073/pnas.93.26.15335
   PubMed Web of Science ®Google Scholar
• Sakamuro D, Sabbatini P, White E, Prendergast GC. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene. 1997;15(8):887–898. doi:10.1038/sj.onc.1201263
   PubMed Web of Science ®Google Scholar
• Birch J, Barnes PJ, Passos JF. Mitochondria, telomeres and cell senescence: implications for lung ageing and disease. Pharmacol Therapeut. 2018;183:34–49. doi:10.1016/j.pharmthera.2017.10.005
   PubMed Web of Science ®Google Scholar
• Taraseviciene-Stewart L, Voelkel NF. Molecular pathogenesis of emphysema. J Clin Invest. 2008;118(2):394–402. doi:10.1172/jci31811
   PubMed Web of Science ®Google Scholar
• Walter MF, Jacob RF, Jeffers B, et al. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease A longitudinal analysis of the PREVENT study. J Am Coll Cardiol. 2004;44(10):1996–2002. doi:10.1016/j.jacc.2004.08.029
   PubMed Web of Science ®Google Scholar
• El-Bassiouni EA, Helmy MH, El-Zoghby SM, Kamel EN, Hosny RM. Relationship between level of circulating modified LDL and the extent of coronary artery disease in type 2 diabetic patients. Brit J Biomed Sci. 2016;64(3):109–116. doi:10.1080/09674845.2007.11732768
   Web of Science ®Google Scholar
• Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta. 2004;339(1–2):1–9. doi:10.1016/j.cccn.2003.09.010
   PubMed Web of Science ®Google Scholar
• Faraci FM, Didion SP. Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol. 2004;24(8):1367–1373. doi:10.1161/01.atv.0000133604.20182.cf
   PubMed Web of Science ®Google Scholar
• Pyne-Geithman GJ, Caudell DN, Prakash P, Clark JF. Glutathione peroxidase and subarachnoid hemorrhage: implications for the role of oxidative stress in cerebral vasospasm. Neurol Res. 2013;31(2):195–199. doi:10.1179/174313209x393906
   Web of Science ®Google Scholar
• Pasquini A, Luchetti E, Marchetti V, Cardini G, Iorio EL. Analytical performances of d-ROMs test and BAP test in canine plasma. Definition of the normal range in healthy Labrador dogs. Vet Res Commun. 2008;32(2):137–143. doi:10.1007/s11259-007-9014-x
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Oxidative stress-based therapeutics in COPD. Redox Biol. 2020;33:101544. doi:10.1016/j.redox.2020.101544
   PubMed Web of Science ®Google Scholar
• Taniguchi A, Tsuge M, Miyahara N, Tsukahara H. Reactive oxygen species and antioxidative defense in chronic obstructive pulmonary disease. Antioxidants. 2021;10(10):1537. doi:10.3390/antiox10101537
   Web of Science ®Google Scholar
• Markoulis N, Gourgoulianis KI, Moulas A, Gerogianni E, Molyvdas AP. Reactive oxygen metabolites as an index of chronic obstructive pulmonary disease severity. Panminerva Med. 2006;48(4):209–213.
   PubMed Web of Science ®Google Scholar
• Yasuo M, Droma Y, Kitaguchi Y, et al. The relationship between acrolein and oxidative stress in COPD: in systemic plasma and in local lung tissue. Int J Chronic Obstr. 2019;14:1527–1537. doi:10.2147/copd.s208633
   PubMed Web of Science ®Google Scholar
• Kato R, Mizuno S, Kadowaki M, et al. Sirt1 expression is associated with CD31 expression in blood cells from patients with chronic obstructive pulmonary disease. Respir Res. 2016;17(1):139. doi:10.1186/s12931-016-0452-2
   PubMed Web of Science ®Google Scholar
• Mizuno S, Ishizaki T, Kadowaki M, et al. p53 signaling pathway polymorphisms associated with emphysematous changes in COPD patients. Chest. 2017;152(1):58–69. doi:10.1016/j.chest.2017.03.012
   PubMed Web of Science ®Google Scholar
• Agusti A, Vogelmeier C, Papi A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: 2021 report. Available from: https://goldcopd.org/2022-gold-reports-2/. Accessed November 22, 2021.
   Google Scholar
• Nojiri M, Mizuno S, Nishiki K, et al. ADRB2 gene polymorphism and emphysema heterogeneity can modulate bronchodilator response in patients with emphysema. Pulm Pharmacol Ther. 2018;48:80–87. doi:10.1016/j.pupt.2017.09.004
   PubMed Web of Science ®Google Scholar
• Nishiki K, Nojiri M, Kato R, et al. Serum Creatinine/Cystatin C ratio associated with cross-sectional area of erector spinae muscles and pulmonary function in patients with chronic obstructive pulmonary disease. Int J Chronic Obstr. 2021;16:3513–3524. doi:10.2147/copd.s339243
   PubMed Web of Science ®Google Scholar
• Tanimura K, Sato S, Fuseya Y, et al. Quantitative assessment of erector spinae muscles in patients with chronic obstructive pulmonary disease. novel chest computed tomography–derived index for prognosis. Ann Am Thorac Soc. 2016;13(3):334–341. doi:10.1513/annalsats.201507-446oc
   PubMed Web of Science ®Google Scholar
• Hirai K, Tanaka A, Homma T, et al. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease. Clin Nutr. 2021;40(3):1274–1280. doi:10.1016/j.clnu.2020.08.010
   PubMed Web of Science ®Google Scholar
• Fischer BM, Voynow JA, Ghio AJ. COPD: balancing oxidants and antioxidants. Int J Chronic Obstr. 2015;10:261–276. doi:10.2147/copd.s42414
   PubMed Web of Science ®Google Scholar
• Antwerpen VLV, Theron AJ, Richards GA, et al. Vitamin E, pulmonary functions, and phagocyte-mediated oxidative stress in smokers and nonsmokers. Free Radical Bio Med. 1995;18(5):935–941. doi:10.1016/0891-5849(94)00225-9
   PubMed Web of Science ®Google Scholar
• Halliwell B. Antioxidants in human health and disease. Annu Rev Nutr. 1996;16(1):33–50. doi:10.1146/annurev.nu.16.070196.000341
   PubMed Web of Science ®Google Scholar
• Kamezaki F, Yamashita K, Kubara T, et al. Derivatives of reactive oxygen metabolites correlates with high-sensitivity C-reactive protein. J Atheroscler Thromb. 2008;15(4):206–212. doi:10.5551/jat.e538
   PubMed Web of Science ®Google Scholar
• Hirose H, Kawabe H, Komiya N, Saito I. Relations between Serum Reactive Oxygen Metabolites (ROMs) and various inflammatory and metabolic parameters in a Japanese population. J Atheroscler Thromb. 2009;16(2):77–82. doi:10.5551/jat.e265
   PubMed Web of Science ®Google Scholar
• Bajpai J, Prakash V, Kant S, et al. Study of oxidative stress biomarkers in chronic obstructive pulmonary disease and their correlation with disease severity in north Indian population cohort. Lung India Official Organ Indian Chest Soc. 2017;34(4):324–329. doi:10.4103/lungindia.lungindia_205_16
   PubMed Web of Science ®Google Scholar
• Folchini F, Nonato N, Feofiloff E, D’Almeida V, Nascimento O, Jardim J. Association of oxidative stress markers and C-reactive protein with multidimensional indexes in COPD. Chron Resp Dis. 2011;8(2):101–108. doi:10.1177/1479972310391284
   PubMed Web of Science ®Google Scholar
• Ishizaka Y, Yamakado M, Toda A, Tani M, Ishizaka N. Relationship between coffee consumption, oxidant status, and antioxidant potential in the Japanese general population. Clin Chem Laboratory Medicine Cclm. 2013;51(10):1951–1959. doi:10.1515/cclm-2013-0146
   Google Scholar
• Waseem SMA, Mobarak MH, Islam N, Ahmad Z. Comparative study of pulmonary functions and oxidative stress in smokers and non-smokers. Indian J Physiology Pharmacol. 2012;56(4):345–352.
   PubMedGoogle Scholar
• Aydemir Y, Aydemir Ö, Şengül A, et al. Comparison of oxidant/antioxidant balance in COPD and non-COPD smokers. Heart Lung. 2019;48(6):566–569. doi:10.1016/j.hrtlng.2019.07.005
   PubMed Web of Science ®Google Scholar
• Sepúlveda-Loyola W, De Castro LA, Matsumoto AK, et al. NOVEL antioxidant and oxidant biomarkers related to sarcopenia in COPD. Heart Lung. 2021;50(1):184–191. doi:10.1016/j.hrtlng.2020.06.001
   PubMed Web of Science ®Google Scholar
• Grochola LF, Zeron-Medina J, Mériaux S, Bond GL. Single-nucleotide polymorphisms in the p53 signaling pathway. Csh Perspect Biol. 2010;2(5):a001032. doi:10.1101/cshperspect.a001032
   PubMed Web of Science ®Google Scholar
• Shenberger JS, Dixon PS. Oxygen induces S-phase growth arrest and increases p53 and p21(WAF1/CIP1) expression in human bronchial smooth-muscle cells. Am J Resp Cell Mol. 1999;21(3):395–402. doi:10.1165/ajrcmb.21.3.3604
   PubMed Web of Science ®Google Scholar
• Kilk K, Meitern R, Härmson O, Soomets U, Hõrak P. Assessment of oxidative stress in serum by d-ROMs test. Free Radical Res. 2014;48(8):883–889. doi:10.3109/10715762.2014.919390
   PubMed Web of Science ®Google Scholar
• Komatsu F, Kagawa Y, Sakuma M, et al. Investigation of oxidative stress and dietary habits in Mongolian people, compared to Japanese people. Nutr Metabolism. 2006;3(1):21. doi:10.1186/1743-7075-3-21
   Google Scholar